No black box warning on record for Ramipril

As of the latest FDA labeling reviewed, Ramipril (RAMIPRIL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ramipril medicine page for the complete safety profile.

Other warnings & precautions

5. WARNINGS AND PRECAUTIONS ACE inhibitor use has been associated with the following: • Angioedema, with increased risk in patients with a prior history ( 5.1 ) • Hypotension and hyperkalemia ( 5.5 , 5.8 ) • Renal impairment: monitor renal function during therapy ( 5.3 ) • Increased risk of renal impairment when combined with another blocker of the renin-angiotensin-aldosterone system ( 5.7 ) • Ra

No black box warning on record for Ramipril

Other warnings & precautions

5. WARNINGS AND PRECAUTIONS ACE inhibitor use has been associated with the following: • Angioedema, with increased risk in patients with a prior history ( 5.1 ) • Hypotension and hyperkalemia ( 5.5 , 5.8 ) • Renal impairment: monitor renal function during therapy ( 5.3 ) • Increased risk of renal impairment when combined with another blocker of the renin-angiotensin-aldosterone system ( 5.7 ) • Ra

Ramipril Black Box Warning

No black box warning on record for Ramipril

Other warnings & precautions

Ramipril Black Box Warning

No black box warning on record for Ramipril

Other warnings & precautions